Organogenesis Holdings Inc (ORGO)
3.135
+0.04
(+1.13%)
USD |
NASDAQ |
Jan 06, 16:00
3.135
0.00 (0.00%)
After-Hours: 16:02
Organogenesis Holdings Total Assets (Quarterly): 446.30M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Plus Therapeutics Inc | 6.978M |
| Poseida Therapeutics Inc | 293.58M |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
| iBio Inc | 24.52M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 167.75M |
| Shareholders Equity (Quarterly) | 278.55M |
| Debt to Equity Ratio | 0.223 |
| Current Ratio | 3.086 |
| Net Debt Paydown Yield | 0.36% |